MOUSE PHENOTYPING, PHYSIOLOGY, AND METABOLISM CORE: Director - R. AhimaOur understanding of the pathogenesis of diabetes has benefited from the use of gene targetingmethodology in mice to elucidate molecular mechanisms. However, such efforts are oftenhampered by an absence of a clear metabolic phenotype. Failure to identify a phenotype may bedue to lack of expertise and/or facilities for evaluating metabolic changes in mice. The MousePhenotyping, Physiology and Metabolism Core provides investigators of the Penn Diabetes andEndocrinology Research Center (DERC) with state-of-the-art, timely and cost-effective diagnosticstudies in mice. The core offers consultation and experimental design, monitoring of feeding,energy expenditure and locomotor activity using the Comprehensive Laboratory Animal MonitoringSystem (CLAMS), treadmill exercise using the Oxymax system, and measurement of bodycomposition using dual emission x-ray absorptiometry (DEXA) and carcass chemistry. Glucosehomeostasis is assessed by oral or intraperitoneal (i.p.) glucose administration, and whole bodyinsulin sensitivity by i.p. insulin injection. Insulin clamp and radioactive tracers are used to assessglucose fluxes and tissue specific glucose uptake. Studies in the core are performed by tworesearch specialists under the direction of Rex Ahima. Future plans for the core include the usemagnetic resonance (MRI) for measurement of water, lean and fat content, assessment of in vivolipid kinetics, and employment of an additional technician to expedite services. The MousePhenotyping, Physiology and Metabolism Core will maintain a databank of metabolic and hormonalparameters in mouse models of diabetes and obesity, and coordinate its activities with other corelaboratories, i.e. Islet Cell Biology (Franz Matschinsky), Radioimmunoassay/Biomarkers (BryanWolf; Muredach Reilly), Transgenic and Chimeric Mouse (Nancy Cooke), and Genomics and GeneTargeting Cores (Klaus Kaestner). These efforts will result in optimum data acquisition andmetabolic phenotyping of mice, and facilitate the translation of ideas from the bench to mice, andultimately to humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK019525-31
Application #
7284633
Study Section
Special Emphasis Panel (ZDK1-GRB-N (J1))
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-05-15
Budget End
2008-03-31
Support Year
31
Fiscal Year
2007
Total Cost
$172,992
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Pickett-Blakely, Octavia; Young, Kimberly; Carr, Rotonya M (2018) Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis. Cell Mol Gastroenterol Hepatol 6:451-462
Kameswaran, Vasumathi; Golson, Maria L; Ramos-Rodríguez, Mireia et al. (2018) The Dysregulation of the DLK1-MEG3 Locus in Islets From Patients With Type 2 Diabetes Is Mimicked by Targeted Epimutation of Its Promoter With TALE-DNMT Constructs. Diabetes 67:1807-1815
Huang, Chen; Walker, Emily M; Dadi, Prasanna K et al. (2018) Synaptotagmin 4 Regulates Pancreatic ? Cell Maturation by Modulating the Ca2+ Sensitivity of Insulin Secretion Vesicles. Dev Cell 45:347-361.e5
Moreira, Leticia; Bakir, Basil; Chatterji, Priya et al. (2018) Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer. Cell Mol Gastroenterol Hepatol 5:289-298
Pei, Liming; Wallace, Douglas C (2018) Mitochondrial Etiology of Neuropsychiatric Disorders. Biol Psychiatry 83:722-730
Brown, Justin C; Rickels, Michael R; Troxel, Andrea B et al. (2018) Dose-response effects of exercise on insulin among colon cancer survivors. Endocr Relat Cancer 25:11-19
Rickels, M R; Markmann, E; Naji, A (2018) Successful pregnancies after islet transplantation for type 1 diabetes. Am J Transplant :
Friedman, Elliot S; Li, Yun; Shen, Ting-Chin David et al. (2018) FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid. Gastroenterology 155:1741-1752.e5
Rickels, Michael R; DuBose, Stephanie N; Toschi, Elena et al. (2018) Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Care 41:1909-1916
Jang, Cholsoon; Hui, Sheng; Lu, Wenyun et al. (2018) The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab 27:351-361.e3

Showing the most recent 10 out of 720 publications